UK begins clinical trial for experimental mRNA therapy for cancer
An 81-year-old man with treatment-resistant malignant melanoma was the first person in the UK to receive the new immunotherapy treatment.
Cancer patients in the...
MHRA approves Bristol Myers Squibb’s Opdualag for advanced melanoma treatment
The American biopharmaceutical company receives marketing authorisation for the drug through Project Orbis
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved...
MHRA gives nod for a new therapy to treat lung cancer
The new therapy is said to 'slow down' or 'stop the growth' of the cancer
The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved...
AstraZeneca boosts cancer portfolio with $320 mln Neogene deal
Pharmaceutical giant AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday (November 29) as it seeks...